Compare Stocks: CMPS, ATAI, MSOS, CURLF, and IIPR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATAI Atai Beckley	$7.34 +0.7%	$6.44	$3.27 ▼ $7.45	$2.72B	1.55	7.75 million shs	5.22 million shs
CMPS Compass Pathways	$13.51 -1.6%	$13.09	$4.40 ▼ $15.40	$1.87B	2.5	3.61 million shs	1.77 million shs
CURLF Curaleaf	$9.62 -0.4%	$8.22	$5.40 ▼ $15.15	$2.25B	1.56	301,338 shs	122,181 shs
IIPR Innovative Industrial Properties	$56.94 +1.1%	$60.31	$44.58 ▼ $65.38	$1.57B	1.38	342,107 shs	550,540 shs
MSOS AdvisorShares Pure US Cannabis ETF	$4.95 -0.8%	$4.55	$2.96 ▼ $7.25	$994.36M	1.34	6.88 million shs	3.92 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATAI Atai Beckley	0.00%	-1.22%	+1.53%	+51.24%	+59.17%
CMPS Compass Pathways	0.00%	+3.00%	+20.97%	-3.24%	+210.63%
CURLF Curaleaf	0.00%	-3.30%	+9.40%	-11.54%	-2.42%
IIPR Innovative Industrial Properties	0.00%	-0.55%	-3.89%	-1.48%	-0.13%
MSOS AdvisorShares Pure US Cannabis ETF	0.00%	+0.60%	+17.97%	-2.35%	-10.41%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATAI Atai Beckley	$7.34 +0.7%	$6.44	$3.27 ▼ $7.45	$2.72B	1.55	7.75 million shs	5.22 million shs
CMPS Compass Pathways	$13.51 -1.6%	$13.09	$4.40 ▼ $15.40	$1.87B	2.5	3.61 million shs	1.77 million shs
CURLF Curaleaf	$9.62 -0.4%	$8.22	$5.40 ▼ $15.15	$2.25B	1.56	301,338 shs	122,181 shs
IIPR Innovative Industrial Properties	$56.94 +1.1%	$60.31	$44.58 ▼ $65.38	$1.57B	1.38	342,107 shs	550,540 shs
MSOS AdvisorShares Pure US Cannabis ETF	$4.95 -0.8%	$4.55	$2.96 ▼ $7.25	$994.36M	1.34	6.88 million shs	3.92 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATAI Atai Beckley	0.00%	-1.22%	+1.53%	+51.24%	+59.17%
CMPS Compass Pathways	0.00%	+3.00%	+20.97%	-3.24%	+210.63%
CURLF Curaleaf	0.00%	-3.30%	+9.40%	-11.54%	-2.42%
IIPR Innovative Industrial Properties	0.00%	-0.55%	-3.89%	-1.48%	-0.13%
MSOS AdvisorShares Pure US Cannabis ETF	0.00%	+0.60%	+17.97%	-2.35%	-10.41%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATAI Atai Beckley	2.06	Hold	$10.56	43.82% Upside
CMPS Compass Pathways	2.88	Moderate Buy	$23.36	72.89% Upside
CURLF Curaleaf	3.60	Strong Buy	N/A	N/A
IIPR Innovative Industrial Properties	1.75	Reduce	$48.00	-15.70% Downside
MSOS AdvisorShares Pure US Cannabis ETF	2.00	Hold	$4.95	N/A

Current Analyst Ratings Breakdown

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	ATAI Atai Beckley	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
8/13/2026	ATAI Atai Beckley	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/12/2026	ATAI Atai Beckley	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$12.00 ➝ $8.00
8/12/2026	ATAI Atai Beckley	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$12.00 ➝ $8.00
8/7/2026	CMPS Compass Pathways	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$70.00 ➝ $65.00
8/6/2026	IIPR Innovative Industrial Properties	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/6/2026	CMPS Compass Pathways	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $18.00
8/6/2026	CURLF Curaleaf	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/6/2026	CMPS Compass Pathways	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$22.00 ➝ $21.00
8/6/2026	CMPS Compass Pathways	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$17.00 ➝ $22.00
8/5/2026	CMPS Compass Pathways	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 8/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATAI Atai Beckley	$4.47M	608.71	N/A	N/A	$0.69 per share	10.64
CMPS Compass Pathways	N/A	N/A	N/A	N/A	($0.55) per share	N/A
CURLF Curaleaf	$1.27B	1.77	$0.16 per share	58.75	$3.34 per share	2.88
IIPR Innovative Industrial Properties	$265.95M	5.90	$7.01 per share	8.12	$64.24 per share	0.89
MSOS AdvisorShares Pure US Cannabis ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATAI Atai Beckley	-$660.05M	-$2.18	N/A	N/A	N/A	-14,938.36%	-88.30%	-58.88%	11/12/2026 (Estimated)
CMPS Compass Pathways	-$287.86M	-$4.62	N/A	N/A	N/A	N/A	-49.63%	-13.08%	11/3/2026 (Estimated)
CURLF Curaleaf	-$231.07M	-$0.13	N/A	N/A	N/A	-2.62%	-0.88%	-0.26%	N/A
IIPR Innovative Industrial Properties	$118.25M	$4.41	12.91	7.40	N/A	52.27%	7.73%	5.69%	11/2/2026 (Estimated)
MSOS AdvisorShares Pure US Cannabis ETF	N/A	N/A	12.20	N/A	N/A	N/A	N/A	N/A	N/A

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/11/2026	Q2 2026	ATAI Atai Beckley	-$0.1075	-$0.09	+$0.0175	-$0.09	$0.60 million	$1.70 million
8/5/2026	Q2 2026	CMPS Compass Pathways	-$0.3881	-$1.88	-$1.4919	-$1.88	N/A	N/A
8/5/2026	Q2 2026	CURLF Curaleaf	-$0.20	$0.05	+$0.25	$0.05	$332.00 million	$340.10 million
8/3/2026	Q2 2026	IIPR Innovative Industrial Properties	$1.02	$1.36	+$0.34	$1.36	$67.09 million	$63.32 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATAI Atai Beckley	N/A	N/A	N/A	N/A	N/A
CMPS Compass Pathways	N/A	N/A	N/A	N/A	N/A
CURLF Curaleaf	N/A	N/A	N/A	N/A	N/A
IIPR Innovative Industrial Properties	$7.60	13.35%	+11.20%	172.34%	4 Years
MSOS AdvisorShares Pure US Cannabis ETF	$0.07	1.41%	N/A	N/A	N/A

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/15/2026	IIPR Innovative Industrial Properties	quarterly	$1.90	12.26%	6/30/2026	6/30/2026	7/15/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATAI Atai Beckley	N/A	N/A	N/A
CMPS Compass Pathways	0.60	1.30	1.30
CURLF Curaleaf	1.06	1.52	0.73
IIPR Innovative Industrial Properties	0.35	24.51	24.51
MSOS AdvisorShares Pure US Cannabis ETF	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATAI Atai Beckley	28.41%
CMPS Compass Pathways	46.19%
CURLF Curaleaf	0.03%
IIPR Innovative Industrial Properties	70.58%
MSOS AdvisorShares Pure US Cannabis ETF	N/A

Insider Ownership

Company	Insider Ownership
ATAI Atai Beckley	19.80%
CMPS Compass Pathways	2.82%
CURLF Curaleaf	N/A
IIPR Innovative Industrial Properties	2.30%
MSOS AdvisorShares Pure US Cannabis ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATAI Atai Beckley	80	370.87 million	297.43 million	Optionable
CMPS Compass Pathways	120	138.48 million	134.57 million	Optionable
CURLF Curaleaf	5,554	233.51 million	N/A	Not Optionable
IIPR Innovative Industrial Properties	20	27.57 million	26.94 million	Optionable
MSOS AdvisorShares Pure US Cannabis ETF	N/A	200.88 million	N/A	Not Optionable

CMPS, ATAI, MSOS, CURLF, and IIPR Headlines

Recent News About These Companies

Stock Traders Purchase High Volume of Call Options on AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS)

August 21, 2026 | americanbankingnews.com

Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD

August 19, 2026 | 247wallst.com

AdvisorShares Pure US Cannabis (MSOS) stock forecast and price target

August 18, 2026 | finance.yahoo.com

MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks

July 9, 2026 | seekingalpha.com

DEA Rescheduling Hearing Puts Cannabis Stocks in Focus Ahead of a July 15 Deadline

July 1, 2026 | investorideas.comI

The Easiest Way to Bet on US Cannabis Is This One ETF

July 1, 2026 | 247wallst.com

Cannabis Stocks Pop As Another U.S. Company Applies to List on NYSE

June 18, 2026 | finance.yahoo.com

Marijuana Stocks to Watch Before the Next Cannabis Rally

May 19, 2026 | marijuanastocks.comM

Dan Ahrens on Pot Stock Outlook & MSOS ETF After Reclassification

May 17, 2026 | youtube.comY

US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?

May 14, 2026 | zacks.com

3 Top Picks For Marijuana Stocks Investors To See Profits In 2026

May 11, 2026 | marijuanastocks.comM

Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021

May 6, 2026 | 247wallst.com

Trump’s Rescheduling of Marijuana Is a Spark for Top Marijuana ETFs (MSOS)

...

May 3, 2026 | marketbeat.com

AdvisorShares Pure US Cannabis ETF : MSOS

May 1, 2026 | 247wallst.com

Cannabis ETFs: Regulatory Momentum Returns Focus

April 30, 2026 | etftrends.comE

Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification

April 30, 2026 | reuters.com

Top U.S. Marijuana Stocks to Watch in April 2026 as the Sector Heats Up

April 28, 2026 | marijuanastocks.comM

4 Best-Performing ETF Areas of Last Week

April 28, 2026 | zacks.com

Medical Marijuana Reclassified as Less Dangerous Drug

April 23, 2026 | barrons.com

The Last Cannabis ETFs Worth Your Money: Why Most Failed and 3 Are Still Trading

April 23, 2026 | 247wallst.com

MSOS: Trump's Green Light - Why Cannabis Stocks Are Surging On Rescheduling News (Rating Upgrade)

April 22, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CMPS, ATAI, MSOS, CURLF, and IIPR Company Descriptions

Atai Beckley NASDAQ:ATAI

$7.34 +0.05 (+0.69%)

As of 04:00 PM Eastern

Atai Beckley N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its product candidates include COMP360, a proprietary psilocybin which is in Phase 3 program; BPL-003, an intranasal formulation that is in Phase 2a and 2b clinical studies; TRD; VLS-01, an transmucosal film in Phase 1b clinical studies; and ELE-101, a serotonergic psychedelic that is in Phase 1/2a study, for the treatment of treatment resistant depression. The company also develop IBX-210, an intravenous formulation of ibogaine, and DMX-1002, an oral formulation of ibogaine indicated for the treatment of opioid use disorder; EMP-01, an oral formulation of an R-MDMA derivative being developed for the treatment of post-traumatic stress disorder; and EGX-A and EGX-B, psychedelic-like with novel, non-tryptamine structures with differentiated 5-HT receptor pharmacology. In addition, it offers RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; and GRX-917, a deuterated etifoxine for the treatment of generalize anxiety disorder. Further, the company develops PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; KUR-101, a formulation of deuterated mitragynine for the treatment of OUD; and RLS-01, indicated for treatment resistant depression. Atai Beckley N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.

Compass Pathways NASDAQ:CMPS

$13.51 -0.22 (-1.60%)

As of 04:00 PM Eastern

Compass Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to Compass Pathways plc in August 2020. Compass Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Curaleaf OTCMKTS:CURLF

$9.62 -0.04 (-0.41%)

As of 03:57 PM Eastern

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

Innovative Industrial Properties NYSE:IIPR

$56.94 +0.63 (+1.12%)

As of 03:58 PM Eastern

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017.

AdvisorShares Pure US Cannabis ETF NYSEARCA:MSOS

$4.95 -0.04 (-0.80%)

As of 04:10 PM Eastern

The AdvisorShares Pure US Cannabis ETF (MSOS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. MSOS was launched on Sep 1, 2020 and is managed by AdvisorShares.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Earnings

Compare Dividends

Latest CMPS, ATAI, MSOS, CURLF, and IIPR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CMPS, ATAI, MSOS, CURLF, and IIPR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CMPS, ATAI, MSOS, CURLF, and IIPR Company Descriptions

Atai Beckley NASDAQ:ATAI

Compass Pathways NASDAQ:CMPS

Curaleaf OTCMKTS:CURLF

Innovative Industrial Properties NYSE:IIPR

AdvisorShares Pure US Cannabis ETF NYSEARCA:MSOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools